The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

International News

South Africa: Comparative Effectiveness of HIV Testing and Treatment in Highly Endemic Regions

November 2, 2010

"Universal testing and treatment holds promise for reducing the burden of [HIV] in sub-Saharan Africa, but linkage from testing to treatment sites and retention in care are inadequate," according to the study's introduction.


The researchers developed an HIV epidemic and disease progression simulation in South Africa to compare the outcomes of the present HIV treatment campaign (status quo) with four HIV testing and treatment strategies that increase access to antiretroviral therapy: (1) universal testing and treatment absent changes in linkage to care and loss to follow-up; (2) universal testing and treatment with enhanced linkage to care; (3) universal testing and treatment with reduced loss to follow-up; and (4) comprehensive HIV care with universal testing and treatment, improved linkage to care and reduced loss the follow-up. Survival benefits, new HIV infections, and HIV prevalence were the main outcome measures.

"Compared with the status quo strategy, universal testing and treatment (1) was associated with a mean (95 percent uncertainty bounds) life expectancy gain of 12.0 months (11.3-12.2 months), and 35.3 percent (32.7 percent-37.5 percent) fewer HIV infections over a 10-year time horizon," the authors reported. Enhanced linkage to care (2), prevention of loss to follow-up (3) and comprehensive HIV care (4) provided substantial additional benefits, they noted: "Life expectancy gains compared with the status quo strategy were 16.1, 18.6 and 22.2 months, and new infections were 55.5 percent, 51.4 percent and 73.2 percent lower, respectively." Sensitivity analysis showed comprehensive HIV care reduced new infections by 69.7 percent to 76.7 percent under a broad set of assumptions.

"Universal testing and treatment with current levels of linkage to care and loss to follow-up could substantially reduce the HIV death toll and new HIV infections," the authors concluded. "However, increasing linkage to care and preventing loss to follow-up provides nearly twice the benefits of universal testing and treatment alone."

Back to other news for November 2010

Adapted from:
Archives of Internal Medicine
08.09.2010; Vol. 170; No. 15: P. 1347-1354; Eran Bendavid, MD, MS; Margaret L. Brandeau, PhD; Robin Wood, MD; Douglas K. Owens, MD, MS

  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
See Also
More on HIV Treatment in South Africa

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining: